• Find a Surgeon
  • ASMH
  • Member Login

Digital Flipbook

Sponsors:
Drs. Kenny Omlin and Nahid Vidal

Project Summary:
Creation of a digital flip book for patients, with goal of making this available for free to ACMS members. The flip book would illustrate common post op scenarios (spitting suture, normal inflammation around incision, flap pin-cushioning, hypopigmentation of graft - to name a few). This is something that must be more patient-friendly than textbooks and offers visuals in a range rather than only optimal outcomes.

Program Participants:

Jason Castillo, MD, FACMS grew up in Clovis, CA.  He is an Assistant Clinical Professor at the Bernard J Tyson School of Medicine, physician lead of the Mohs Surgery Department at Kaiser Permanente Orange County, and volunteer associate faculty at the Harbor-UCLA Division of Dermatology Residency Program.  Dr. Castillo earned his medical degree at UCSF followed by dermatology residency at Harbor-UCLA where he served as Chief Resident. He completed a Micrographic Surgery and Dermatologic Oncology Fellowship at Mayo Clinic in Rochester, MN.  His clinical interests include immunohistochemistry during Mohs, resident and medical student curriculum development and education, and diversity/inclusion advocacy. 

 

Ramin Fathi, MD, FACMS is the Director of Phoenix Surgical Dermatology Group and clinical faculty at Mayo Clinic Arizona. Dr. Fathi attended medical school at Rush Medical College in Chicago, IL. Following medical school, he completed his dermatology residency at the University of Colorado-Denver, and then completed a fellowship in Mohs Micrographic Surgery and Dermatologic Oncology at the University of Texas - Southwestern. Dr. Fathi specializes in Mohs micrographic surgery, cosmetic dermatology, and high-risk skin cancers. He is the chair of the ACMS Communications and Public Relations Committee. Dr. Fathi has a special interest in reconstructive surgery/techniques, medical education and practice improvement. 

 

Bridget McIlwee, DO, FAAD, FAOCD was born in Texas and raised in Chicagoland. She earned her BA in chemistry and minors in psychology, political science, and French at the University of Dayton, including studies abroad at l’Institut Catholique de Paris and al Akhawayn University in Morocco. She attended medical school at the Chicago College of Osteopathic Medicine at Midwestern University, followed by dermatology residency at the University of North Texas Health Science Center. She completed dermatopathology fellowship at ProPath in Dallas, Texas, followed by Mohs micrographic surgery and dermatologic oncology fellowship at The Ohio State University Wexner Medical Center. Dr. McIlwee is a prior member of the American Osteopathic Association Board of Trustees, the American Osteopathic College of Dermatology Board of Trustees, the Accreditation Council for Graduate Medical Education (ACGME) Osteopathic Principles Committee, and ACGME Council of Review Committee Residents. She is a current member of the Work and Advisory Group for the ACGME Back to Bedside initiative. She also serves on the AAD Young Physicians Committee, authoring the monthly Young Physician Focus column in the AAD’s DermWorld publication. She is passionate about healthcare reform and political advocacy, mental health and wellness, and diversity, equity, and inclusion in medicine.

 

Kiyanna Williams, MD

 

 

 

 

Mohs Workforce Adequacy

Sponsors:
Drs. Marta Van Beek and Hao Feng

Project Summary:
It is unclear how MDS board certification will affect access to care for skin cancer patients. As of 2022, approximately 70% of board-certified Mohs surgeons are fellowship-trained. Over time, this percentage will increase to 100% as the clinical pathway closes and the certification is limited to fellowship-trained physicians. Moreover, it is possible that insurers could require MDS board certification for payment for Mohs surgery services. There is concern that the number of Mohs surgeons may be inadequate to meet the demand for our services. The Mohs college is ill-equipped to define the demand for Mohs surgery today, in five years, in 20 years. This project will work to define the demand for Mohs surgery and the factors that affect this over time. Current workforce adequacy will also be evaluated as well as projections for the future. This project will help define a role for the ACMS in positioning the College and its members in meeting this demand.

Program Participants:

Ji Won Ahn, MD, originally from South Korea, received her Bachelor's degree from Williams College in Mathematics. She completed medical school at Washington University in St. Louis School of Medicine, followed by Dermatology residency at the University of Michigan and a fellowship in Micrographic Surgery and Dermatologic Oncology at Mayo Clinic. She currently practices at the University of Pittsburgh Medical Center, where she is an Assistant Professor. Her academic interests include resident and fellow education, skin of color education, quality improvement initiatives, immunohistochemistry, and complex cutaneous tumors and reconstruction. She also has a special passion for creating a professional, inclusive, and respectful workplace. 

 

Charlene Lam, MD, MPH, FACMS

 

 

 

 

Jeffrey Scott, MD, FACMS is the Director of the Cutaneous Surgery and Oncology Unit at Johns Hopkins School of Medicine and an Assistant Professor of Dermatology. Prior to joining the faculty in the Johns Hopkins Department of Dermatology in 2019, Dr. Scott attended medical school at Yale and was awarded a Howard Hughes Medical Institute Medical Research Training Fellowship. After medical school, he completed his dermatology residency and fellowship in Micrographic Surgery and Dermatologic Oncology at Case Western Reserve University, University Hospitals Cleveland Medical Center. Dr. Scott specializes in Mohs micrographic surgery and the management of high-risk and rare skin cancers. His research interests include defining quality and demonstrating value in dermatologic surgery, conducting health services research in dermatology, measuring patient-reported outcomes in skin cancer treatment, and advancing evidence-based management of high-risk and rare skin cancers. He lives in Maryland with his wife and two daughters.

Sherry Yu, MD is a Staff Physician in the Dermatology and Plastic Surgery Institute at Cleveland Clinic. She practices Mohs surgery and aesthetic dermatology.  Sherry completed her dermatology residency at the Harvard Combined Dermatology Residency Training Program and dermatologic surgery fellowship at Yale University prior to joining Cleveland Clinic in 2021.  She has extensive leadership experience and involvement in hospital supply chain and logistics, organized medicine, and clinical innovations. She currently serves on the Faculty Council at the Case Western Reserve University School of Medicine. 

 

 

Mentors

John G. Albertini, MD, FACMS has practiced at The Skin Surgery Center in NC since 2002, following active duty in the Air Force. Dr. Albertini served as surgical faculty and later as fellowship director of an ACMS and ACGME approved training program in Mohs surgery and Procedural Dermatology from 2002-2013. He currently helps train residents as a volunteer associate professor at Wake Forest University Department of Plastic and Reconstructive Surgery. Dr. Albertini is a past president of the NC Dermatology Association and the American College of Mohs Surgery, having served on the Board of Directors and as member and chair of numerous committees, including currently the Improving Wisely program. He is a frequent lecturer and author on appropriate and quality care, Mohs surgery, and advanced reconstruction.

Sarah Arron, MD, FACMS is originally from New York City. A graduate of Harvard University and Cornell University Medical College, she moved to the San Francisco Bay Area in 2003 for her dermatology residency and Mohs micrographic surgery fellowship at UCSF.  Before joining Peninsula Dermatology in Burlingame, she served for twelve years on the faculty in Dermatology at UCSF, where she was the Associate Director of the UCSF Dermatologic Surgery and Laser Center, and Chief of Mohs Micrographic Surgery at the San Francisco VA Medical Center.

Dr. Arron is board certified in dermatology and clinical informatics, and is fellowship trained in Mohs micrographic surgery. She is a Fellow of the American Academy of Dermatology and the American College of Mohs Surgery.  She has served on the Board of Directors of the ACMS and as President of the International Transplant Skin Cancer Collaborative. Dr. Arron has a special interest in treating skin cancer and the expertise to offer a variety of therapeutic options to her patients. She has published extensively in the field and spoken at numerous national and international conferences. She is also an expert in aesthetic dermatology, including Botox, fillers, lasers, and chemical peels.

Jeremy Bordeaux, MD, MPH, FACMS currently serves as the Director of Dermatologic Surgery, the Director of the Multidisciplinary Cutaneous Oncology Tumor Board, and the Micrographic Surgery and Dermatologic Oncology Fellowship Director at University Hospitals Cleveland Medical Center.  In addition he is a Professor of Dermatology at Case Western Reserve University School of Medicine.  He received his MD from Duke University School of Medicine and his MPH from the University of North Carolina at Chapel Hill.  He then completed his residency in Dermatology and his fellowship in Mohs Micrographic Surgery, Cutaneous Oncology and Cutaneous Reconstruction at UMass Medical School.  His clinical and research interests include advanced cutaneous reconstruction and the epidemiology and prevention of skin cancers.  He also enjoys mentoring medical students, residents, fellows, and faculty.

Jerry Brewer, MD, MS, FACMS has been a member of the Mayo Clinic staff since 2009, currently serves as the Micrographic Surgery and Dermatologic Oncology Fellowship program director and is a Professor of Dermatology. Dr. Brewer’s areas of interest include cutaneous oncology with a focus on melanoma, high risk nonmelanoma skin cancer, vein surgery, and hyperhidrosis. Dr. Brewer received the Penfil Award as a 4th year medical student, the Mayo Brothers Distinguished Fellowship Award as a graduating resident and the Karis Award in 2012 by the Saint Mary’s Hospital Sponsorship Board in recognition of exceptional performance in demonstrating Mayo Clinic values. Dr. Brewer has been on various subcommittees of the American Academy of Dermatology, has served as president of the Minnesota Dermatologic Society (MDS) as well as on the board of directors of the international transplant skin cancer collaborative (ITSCC) and the American College of Mohs Surgery (ACMS). Dr. Brewer’s interests outside of medicine include running (he has successfully completed 4 marathons, and a few half marathons), cooking (is an avid fan of Bon Appetite Magazine), coaching soccer, taekwondo, medical humanitarian missions, and traveling and spending time with his wife and 7 children.

Christopher J. Miller, MD, FACMS is a Professor of Dermatology and the Director of the Penn Dermatology Oncology Center at the Hospital of the University of Pennsylvania.  He earned his medical degree at Jefferson Medical College of Thomas Jefferson University in 2000 and his bachelor's at the University of Notre Dame in 1996.  Dr. Miller’s clinical practice focuses on the use of Mohs micrographic surgery and reconstructive surgery to treat patients with skin cancers, particularly melanomas of the head and neck and advanced tumors.  He supplements his clinical practice with research concentrating on the clinical and epidemiologic aspects of various skin cancers. Dr. Miller’s recent research evaluates the efficacy of Mohs surgery for melanomas of the head and neck and advanced reconstructive surgery techniques.  He also continues to investigate his special interests in advanced techniques of Mohs micrographic surgery, dermatologic surgery education, and service excellence in health care delivery.

Kishwer S. Nehal, MD, FACMS is a graduate of Boston University School of Medicine and she completed her Dermatology residency and Mohs fellowship at New York University. Dr. Nehal joined Memorial Sloan Kettering Cancer Center (MSKCC) in New York City in 1998 and developed the skin cancer surgery program. She is currently the Director of Mohs and Dermatologic Surgery and Attending Physician at MSKCC and Professor of Dermatology at Weill Cornell. Dr. Nehal leads the Multidisciplinary Skin Cancer Management Program at MSKCC providing comprehensive care for patients with high risk, complex, and advanced skin cancers in a multidisciplinary setting. Dr. Nehal serves on the National Comprehensive Cancer Network panel for nonmelanoma skin cancers and development of clinical practice guidelines. She has also served on the American Joint Committee on Cancer expert panel to develop staging for cutaneous squamous cell carcinoma. Her clinical research in noninvasive imaging in collaboration with the optical imaging team at MSKCC has led to advances in real-time skin cancer imaging to guide surgery. She has published extensively on cutaneous oncology including lentigo maligna melanoma and is the author of 137.

Rajiv Nijhawan, MD, FACMS is an Associate Professor of Dermatology at the University of Texas Southwestern Medical Center, where he also serves as the Assistant Fellowship Director of the Mohs fellowship program, the Director of the Parkland Memorial Hospital Skin Tumor Clinic, and the Director of the High Risk Skin Cancer Transplant Clinic. He has a strong interest in high-risk skin cancers in immunosuppressed patient populations as well as advanced reconstruction. 

 

Ashley Wysong, MD, MS, FACMS is the University of Nebraska Department of Dermatology Founding Chair and William W. Bruce MD Distinguished Chair of Dermatology.  She also serves as the Director of the Skin Cancer Program at the Fred & Pamela Buffett Cancer Center and Chief of Dermatology at the Nebraska-Western Iowa Veterans Health Care System. Dr. Wysong is a cancer epidemiologist and translational scientist with a special interest and expertise in locally advanced non-melanoma skin cancer, as well as the treatment of rare skin tumors. She serves as a member of the ACMS Board of Directors and was the Chair of the 2022 ACMS Annual Meeting and Scientific Advisory Committee.

Cookie Notice

We use cookies to ensure you the best experience on our website. Your acceptance helps ensure that experience happens. To learn more, please visit our Privacy Notice.

OK